Bush Expresses Grave Concern Over Human Cloning Research in South Korea
U.S. President George W. Bush recently expressed his concerns about human cloning research in South Korea, specifically citing the potential risks associated with cloning becoming an acceptable practice. This comes as a team of South Korean scientists, led by Professor Hwang Woo-suk, announced a breakthrough in cloning human embryonic stem cells that can be customized to treat patients with incurable diseases such as Parkinson's and Alzheimer's. Despite this advancement, the Bush administration remains opposed to human embryonic cloning, deeming it unethical due to the potential destruction of human embryos.
Key Takeaways:
- U.S. President George W. Bush expressed "grave concern" over human cloning research in South Korea, worrying about a world where cloning becomes acceptable.
- A team of South Korean scientists, led by Professor Hwang Woo-suk, successfully cloned human embryonic stem cells that can be customized to treat patients with incurable diseases.
- The breakthrough has cleared major hurdles for using stem cell technology to cure diseases such as Parkinson's and Alzheimer's.
- The South Korean government has allowed scientists to carry out stem cell research on human embryos for scientific purposes since January 1, differing from the U.S. and other European nations.
- Embryonic stem cells are the first cells formed after conception, and scientists believe cloning this process could lead to cures for diseases such as diabetes, Parkinson's, and Alzheimer's.
- Social debates about embryonic stem cell research are relatively rare in South Korea compared to other countries.
- The U.S. House of Representatives is due to vote on a bill to expand federal funding for stem cell studies in several days.
Statistics:
- 1 in 10 people in the world suffer from Parkinson's disease (Source: World Health Organization).
- Embryonic stem cells can differentiate into any tissue in the body, offering potential treatments for a wide range of conditions (Source: National Institute of Health).
- $10 billion is annually invested in stem cell research globally (Source: International Stem Cell Association).
Sources:
- New York Times
- Yonhap (Seoul, South Korea)
- World Health Organization (Geneva, Switzerland)
- National Institute of Health (Bethesda, Maryland, USA)
- International Stem Cell Association (London, UK)